Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACROBAT EDGE: CRN00808 in acromegaly patients on somatostatin analogue regimens
2018-002230-20Phase 2Completed
- Sponsor
- Crinetics Pharmaceuticals
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paltusotine in acromegaly, sponsored by Crinetics Pharmaceuticals. Primary endpoint: Change in IGF-1 level at Week 13. Started Sep 2018; status: completed.
02
Drugs
paltusotine
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2018-002230-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002230-20.